Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana

Authors

Seatla, K.K., Avalos, A., Moyo, S., Mine, M., Diphoko, T., Mosepele, M., Gaolatlhe, T., Rowley, C.F., Ramaabya, D., Jarvis, J.N., Kasvosve, I., Gaseitsiwe, S.